DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,507,591 | +2.5% | 227,761 | -0.9% | 0.23% | +4.6% |
| Q2 2023 | $55,154,748 | +1.6% | 229,811 | +6.7% | 0.22% | -3.6% |
| Q1 2023 | $54,297,072 | +10.4% | 215,430 | +16.2% | 0.22% | +5.2% |
| Q4 2022 | $49,200,506 | +14.2% | 185,368 | +11.1% | 0.21% | +6.0% |
| Q3 2022 | $43,076,000 | +26.1% | 166,776 | +23.7% | 0.20% | +31.4% |
| Q2 2022 | $34,173,000 | -17.5% | 134,795 | -4.5% | 0.15% | -11.6% |
| Q1 2022 | $41,400,000 | -15.5% | 141,139 | -5.3% | 0.17% | -13.9% |
| Q4 2021 | $49,015,000 | +10.6% | 148,977 | +2.4% | 0.20% | +1.5% |
| Q3 2021 | $44,304,000 | +17.0% | 145,528 | +3.1% | 0.20% | +12.5% |
| Q2 2021 | $37,871,000 | +39.6% | 141,119 | +17.1% | 0.18% | +25.7% |
| Q1 2021 | $27,134,000 | +9.3% | 120,554 | +7.8% | 0.14% | +1.4% |
| Q4 2020 | $24,832,000 | +6.7% | 111,786 | +3.5% | 0.14% | -8.0% |
| Q3 2020 | $23,264,000 | +2.1% | 108,037 | -17.1% | 0.15% | -8.0% |
| Q2 2020 | $22,792,000 | +287.5% | 130,300 | +206.6% | 0.16% | +226.0% |
| Q1 2020 | $5,882,000 | -76.9% | 42,497 | -74.4% | 0.05% | -74.1% |
| Q4 2019 | $25,435,000 | +4946.6% | 165,725 | +4651.3% | 0.19% | +4725.0% |
| Q3 2019 | $504,000 | -1.2% | 3,488 | -2.3% | 0.00% | 0.0% |
| Q2 2019 | $510,000 | +6.7% | 3,571 | -1.3% | 0.00% | 0.0% |
| Q1 2019 | $478,000 | +5.5% | 3,619 | -17.5% | 0.00% | 0.0% |
| Q4 2018 | $453,000 | -13.5% | 4,389 | -9.0% | 0.00% | -20.0% |
| Q3 2018 | $524,000 | +6.7% | 4,823 | -3.2% | 0.01% | 0.0% |
| Q2 2018 | $491,000 | -10.6% | 4,980 | -11.2% | 0.01% | -16.7% |
| Q1 2018 | $549,000 | -23.5% | 5,608 | -27.5% | 0.01% | -14.3% |
| Q4 2017 | $718,000 | +32.5% | 7,731 | +22.4% | 0.01% | +16.7% |
| Q3 2017 | $542,000 | +2.7% | 6,317 | +1.0% | 0.01% | -14.3% |
| Q2 2017 | $528,000 | -6.7% | 6,253 | -5.6% | 0.01% | 0.0% |
| Q1 2017 | $566,000 | +10.3% | 6,622 | +0.5% | 0.01% | -12.5% |
| Q4 2016 | $513,000 | -3.8% | 6,592 | -3.1% | 0.01% | 0.0% |
| Q3 2016 | $533,000 | -28.9% | 6,805 | -8.4% | 0.01% | -38.5% |
| Q2 2016 | $750,000 | -24.2% | 7,425 | -28.8% | 0.01% | -23.5% |
| Q1 2016 | $989,000 | -18.2% | 10,424 | -19.9% | 0.02% | -22.7% |
| Q4 2015 | $1,209,000 | +98.8% | 13,013 | +82.5% | 0.02% | +266.7% |
| Q3 2015 | $608,000 | -76.1% | 7,130 | -76.0% | 0.01% | -88.7% |
| Q2 2015 | $2,546,000 | +3.6% | 29,738 | +2.7% | 0.05% | +1.9% |
| Q1 2015 | $2,458,000 | +1.3% | 28,952 | +2.2% | 0.05% | -1.9% |
| Q4 2014 | $2,427,000 | +12.8% | 28,316 | -0.0% | 0.05% | +6.0% |
| Q3 2014 | $2,152,000 | -5.7% | 28,328 | -2.2% | 0.05% | +2.0% |
| Q2 2014 | $2,281,000 | -43.2% | 28,968 | -45.9% | 0.05% | -50.0% |
| Q1 2014 | $4,015,000 | +42.7% | 53,536 | +46.9% | 0.10% | +46.3% |
| Q4 2013 | $2,813,000 | +2.1% | 36,441 | -8.3% | 0.07% | -4.3% |
| Q3 2013 | $2,756,000 | – | 39,757 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |